FDA
-
-
-
-
-
-
-
WPD Pharmaceuticals Licensor Announces Confirmatory in Vitro Analysis of WP1122
-
-
-
-
-
-
-
WPD Pharmaceuticals’ Annamycin Received Positive Interim Results From Phase 1/2 Clinical Studies in Acute Myeloid Leukemia
-
-
-
326,855 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

